Inclusion Criteria
Patients must have the following:
- Stage 1 or 2 Walter Reed clinical staging of HIV infected individuals.
- The ability to understand and sign a written informed consent form, which must be obtained prior to study entry.
- Be available for 24 weeks so that follow up may be completed.
- Qualify for care as Department of Defense health care beneficiary.
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
- Prior history of clinically significant cardiac, pulmonary, hepatic, renal, neurologic or autoimmune disease, other than HIV-1 infection, and in less than average general health as determined by a medical history, physical examination, and the required laboratory test results.
Concurrent Medication:
Excluded:
- Corticosteroids or other known immunosuppressive drugs.
- Any experimental agents.
Patients with the following are excluded:
- Prior history of clinically significant cardiac, pulmonary, hepatic, renal, neurologic or autoimmune disease, other than HIV-1 infection, and in less than average general health as determined by a medical history, physical examination, and the required laboratory test results.
Prior Medication:
Excluded within 30 days of study entry:
- Zidovudine or other anti-retroviral agents.
Purpose
